Walk and Talk: Connecting People With Psoriasis
Launched by ROYAL FREE HOSPITAL NHS FOUNDATION TRUST · Dec 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Walk and Talk: Connecting People With Psoriasis" clinical trial is exploring a group walking program designed for individuals with psoriasis, a skin condition that can lead to social isolation. The main goal of the study is to see how acceptable this walking group is to participants and to figure out the best way to organize it. Researchers want to understand how this program might improve people's social connections, increase physical activity, and enhance overall well-being. They are also looking to gather information on the number of participants needed for a future, larger study, as there has been little research on social activities for those with psoriasis.
To participate in this trial, individuals must be 18 years or older, have a diagnosis of psoriasis, and be currently receiving care for their condition. Participants should be able to walk for 30 minutes at a slow pace or be wheelchair users with a caregiver who can assist them. Unfortunately, people who cannot understand the study materials or who do not speak English well enough to complete necessary questionnaires will not be eligible. This study aims to create a supportive environment where people with psoriasis can connect with each other, share experiences, and improve their health together.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or over
- • Diagnosed with psoriasis
- • Currently attending psoriasis services in secondary care
- • Must be able to walk for 30 minutes at a slow pace (approx 2km). Or be a wheelchair user with a carer who can push up hills if necessary
- Exclusion Criteria:
- • Participants who are not capable of understanding the information leaflet or consent form and thus are unable to give informed consent.
- • Participants who do not understand verbal explanations or written information given in English will be excluded, as a number of questionnaires need to be completed. The translation service provided to the hospital is usually telephone operated.
- • Participants not able to walk at a slow pace for 30 minutes will be excluded or wheelchair users who do not have a carer who can help to push up hills.
- • Children will be excluded from study as this study involves making social interactions and contact with adults. This would not be appropriate, as child protection screens will not be performed on participants
About Royal Free Hospital Nhs Foundation Trust
The Royal Free Hospital NHS Foundation Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to high-quality patient care, innovative research, and clinical excellence. As a prominent clinical trial sponsor, the Trust plays a pivotal role in advancing medical knowledge and improving treatment options across various specialties. With a strong emphasis on collaboration and ethical standards, the Trust facilitates robust clinical trials that contribute to the development of new therapies and enhance patient outcomes. Its dedication to research is supported by a team of experienced professionals who ensure rigorous adherence to regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Greater London, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported